Medical News

RSS

Wide-scale study of flu vaccine's effectiveness in European children needed

A wide-scale study of the effectiveness of flu vaccine in children is needed in Europe to fully assess the benefits, not only in keeping the kids from getting sick, but limiting the spread of flu to adults.

4 Dec 2010

ETP, EF announce latest grant recipients of New Therapy Grants Program

The Epilepsy Therapy Project and the Epilepsy Foundation today announced the latest grant recipients of their New Therapy Grants Program, a unique joint venture of two non-profit epilepsy organizations, to advance promising epilepsy research in clinical development.

4 Dec 2010

Increase in suicide rates underestimated

Ian Rockett, Ph.D, M.P.H., professor of epidemiology and associate chair of the West Virginia University Department of Community Medicine, isn't buying the story the suicide numbers are telling.

4 Dec 2010

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

4 Dec 2010

Healthy People 2020 targets barriers to breastfeeding

For the first time, the barriers to breastfeeding are being addressed at the highest level of government. With the release today of Healthy People 2020, the U.S. Department of Health and Human Services has targeted the new 10-year goals for our nation's health - and supporting breastfeeding is prominent among them.

4 Dec 2010

Pharnext receives French approval for Pleodrug Phase II clinical trial in Charcot-Marie Tooth disease type 1A

Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company's Pleotherapy™ technology platform in patients suffering from Charcot-Marie Tooth disease type 1A (CMT1A.

4 Dec 2010

LHC Group alters 2010 guidance due to reduction in Medicare reimbursement

LHC Group, Inc., a national provider of home health and hospice services, announced today that the Company is adjusting its full year earnings per share outlook for 2010 solely due to the 4.89% reduction to Medicare reimbursement that was outlined in the Centers for Medicare & Medicaid Services Home Health Prospective Payment System Rate Update for Calendar Year 2011, which was released on November 3, 2010, following the Company's third quarter earnings call.

4 Dec 2010

HHS, CCSC establish new national awards program

The US Department of Health and Human Services and the Critical Care Societies Collaborative have established a new national awards program. The National Awards Program to Recognize Achievements in Eliminating Healthcare-Associated Infections will annually recognize teams of critical care professionals and healthcare institutions that achieve excellence and notable, sustained improvements in preventing healthcare-associated infections, specifically infections in critical care.

4 Dec 2010

Companies, media organizations join Georgia Prostate Cancer Coalition to launch pledge campaign

Prostate cancer is a serious health concern in Georgia. According to the American Cancer Society, the state of Georgia ranks 11th in number of estimated deaths per capita from the disease. In an effort to raise awareness about prostate cancer and ensure more men commit to be informed and screened, several companies and media organizations have joined the Georgia Prostate Cancer Coalition in launching a pledge campaign.

4 Dec 2010

Music benefits patients on mechanical ventilation

The benefits of listening to music for patients on mechanical ventilation was revealed in a systematic review by a team of Cochrane researchers led by Drexel University College of Nursing and Health Professions associate professor Dr. Joke Bradt. The review found that listening to music may relax patients and potentially result in fewer complications.

4 Dec 2010

Decrease in physician reimbursement leads to decline in AST usage for prostate cancer

The use of androgen suppression therapy (AST) in prostate cancer for low-risk cases declined following a decrease in physician reimbursement, according to a study published online TK in The Journal of the National Cancer Institute. However, the indicated use of AST for metastatic disease in the palliative setting did not decline in the same period.

4 Dec 2010

Pfizer plans regulatory submissions of bosutinib for CML based on BELA study

Pfizer Inc. announced today it is planning regulatory submissions of bosutinib in patients with chronic myeloid leukemia (CML) based on data from a clinical program evaluating the compound in newly diagnosed and previously treated patients. These regulatory submissions are planned for 2011.

4 Dec 2010

IOM releases new dietary recommendations for calcium, vitamin D intakes

The Institute of Medicine recently released new dietary recommendations for calcium and vitamin D intakes, known as Dietary Reference Intakes, used broadly by health professionals and policy makers to guide consumers' dietary patterns. Citing a strong body of new scientific evidence, the IOM based their recommendations on bone health outcomes, confirming the importance of vitamin D and calcium in promoting bone growth and maintenance through various stages of life.

4 Dec 2010

Chaperone protein study could lead to effective therapies for Alzheimer's, neurological disorders

Dynamic regulation of the chaperone protein Hsp27 was required to get rid of abnormally accumulating tau in the brains of mice genetically modified to develop the memory-choking tau tangles associated with Alzheimer's disease, a University of South Florida-led study found.

4 Dec 2010

United Science licenses ion selective electrode sensor technology from University of Minnesota

United Science, a Minnesota startup company, has licensed sensor technology developed at the University of Minnesota that could prevent toxic byproducts of mining and other industries from ending up in the environment and improve productivity at the same time.

4 Dec 2010

Sermo releases report on potential replacements for warfarin

Sermo, the world's largest online community for physicians, today announced a free Sermo Report titled, "Potential Replacements for Coumadin (warfarin)." The report gathered feedback from physicians about awareness and understanding of these products and potential barriers to prescribing.

4 Dec 2010

Neurostimulation effective for management of chronic pain

St. Jude Medical, Inc., a global medical device company, today announced two-year results in a post-market clinical study evaluating neurostimulation (spinal cord stimulation) for the management of chronic low back pain. Presented at the 14th annual North American Neuromodulation Society (NANS) meeting in Las Vegas, the study found that 70 percent of neurostimulation patients reported overall pain relief of 50 percent or better at their final two-year visit.

4 Dec 2010

New web-based CME program to improve cancer care in rural areas

Nearly a quarter of Americans live in rural areas, which consistently report higher cancer mortality rates than urban and suburban areas. Among the complex causes for this disparity is that only 10 percent of physicians practice in rural areas and almost 4 out of 10 rural residents live at least an hour from an urban area. Finding the time, transportation, and financial resources for travel to urban academic medical centers, the standard bearers for quality cancer care, often proves difficult.

4 Dec 2010

Onconova announces three presentations on Estybon- (ON 01910.Na) at ASH 2010

Onconova Therapeutics announces its late-stage anticancer agent, Estybon- (ON 01910.Na), will be featured in three presentations at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, FL, December 4-7, 2010.

4 Dec 2010

African, Caribbean, Pacific, EU leaders meet to discuss maternal mortality, climate change, other issues

Leaders from the African, Caribbean and Pacific (ACP) group of nations and the European Union launched "wide-ranging talks" in Kinshasa, Democratic Republic of Congo, on Thursday, Agence France-Presse reports. Approximately 450 lawmakers from 110 countries attended the opening.

4 Dec 2010

Medical News

Wide-scale study of flu vaccine's effectiveness in European children needed

ETP, EF announce latest grant recipients of New Therapy Grants Program

Increase in suicide rates underestimated

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Healthy People 2020 targets barriers to breastfeeding

Pharnext receives French approval for Pleodrug Phase II clinical trial in Charcot-Marie Tooth disease type 1A

LHC Group alters 2010 guidance due to reduction in Medicare reimbursement

HHS, CCSC establish new national awards program

Companies, media organizations join Georgia Prostate Cancer Coalition to launch pledge campaign

Music benefits patients on mechanical ventilation

Decrease in physician reimbursement leads to decline in AST usage for prostate cancer

Pfizer plans regulatory submissions of bosutinib for CML based on BELA study

IOM releases new dietary recommendations for calcium, vitamin D intakes

Chaperone protein study could lead to effective therapies for Alzheimer's, neurological disorders

United Science licenses ion selective electrode sensor technology from University of Minnesota

Sermo releases report on potential replacements for warfarin

Neurostimulation effective for management of chronic pain

New web-based CME program to improve cancer care in rural areas

Onconova announces three presentations on Estybon- (ON 01910.Na) at ASH 2010

African, Caribbean, Pacific, EU leaders meet to discuss maternal mortality, climate change, other issues

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News